What was Privi Speciality Chemicals's revenue in Q4 FY26?

Privi Speciality Chemicals reported revenue of ₹722 Cr in Q4 FY26, a +15.29% change year-over-year.

Did Privi Speciality Chemicals management deliver on previous promises?

Scorecard data is being built as historical quarters are processed.

PRIVISPECIALITYCHEMICALS Manufacturing 15 May 2026

Privi Speciality Chemicals Ltd — Q4 FY26

Q: What guidance did Privi Speciality Chemicals management give?

Revenue growth of ~20% in FY27: Management expects ~20% revenue growth on standalone basis for FY27, driven by volume and new capacities.

Privi Speciality Chemicals delivered a strong Q4 FY26 with revenue of ₹725.7 Cr (+15.3% YoY) and EBITDA of ₹184.4 Cr (+25.1% YoY), driven by volume growth, price increases, and improved product mix.

Revenue ₹722 Cr +15.29%

EBITDA ₹184 Cr +25.09%

PAT ₹94 Cr +50.48%

EBITDA Margin 25% +200bps

Duration 59 min

Read Time 1 min read

✓ Verified against BSE filing

2-Minute Summary

✦ AI-Generated from Full Transcript

Privi Speciality Chemicals delivered a strong Q4 FY26 with revenue of ₹725.7 Cr (+15.3% YoY) and EBITDA of ₹184.4 Cr (+25.1% YoY), driven by volume growth, price increases, and improved product mix. EBITDA margin expanded to 25.4% (+200 bps YoY) due to cost optimization and operational efficiencies. PAT surged 50.5% to ₹95.7 Cr. For FY26, revenue grew 21.7% to ₹2,582.9 Cr, with EBITDA margin of 25.8%. Management guided for ~20% revenue growth in FY27 with sustained 25%+ EBITDA margins, supported by capacity expansion to 54,000 MT by June 2026 and new specialty products (maltol, cyclopentanone) commercializing by Q1 FY27. The JV with Privi turned profitable in Q4. Key risk: raw material price volatility and supply chain disruptions from geopolitical tensions could pressure margins.

Risks4 trackedTranscriptfull text

Research workspace

Focused Modules

!Risks 4 risks

Risk Intelligence

Raw material price volatility and supply chain disruptions

View Risks →

≡Transcript Full text

Call Transcript

Full transcript text is available on this route.

Read Transcript →

Quarter Snapshot

Total Sales Volume (FY26) 42,389 MT

+6.5% YoY

Volume growth contributed ~6.5% to revenue growth; balance from price/mix.

Net Debt to EBITDA 1.33x

flat

Net debt stood at ₹876 Cr; ratio reflects healthy leverage.

Working Capital Cycle 117 days

-3 days YoY

Improved working capital management; expected to remain near current levels.

ROE / ROCE (FY26) 22.05% / 22.42%

+420 bps / +450 bps YoY

Strong profitability drove returns above 20% threshold.

Fast read

Guidance and risk preview

Top guidance Revenue growth of ~20% in FY27

Management expects ~20% revenue growth on standalone basis for FY27, driven by volume and new capacities.

Top risk Raw material price volatility and supply chain disruptions

Geopolitical tensions (West Asia) could increase freight costs and delay raw material shipments, impacting margins.

View Risks →